Firocoxib is a cycooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug. It currently approved for veterinary use in dogs and horses under the brand names Equioxx and Previcox. Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses. Firocoxib is not intended or approved for use in human medicine.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Amlodipine | Firocoxib may decrease the antihypertensive activities of Amlodipine. |
| Phentermine | The risk or severity of hypertension can be increased when Phentermine is combined with Firocoxib. |
| Midodrine | The risk or severity of hypertension can be increased when Midodrine is combined with Firocoxib. |
| Eletriptan | The risk or severity of hypertension can be increased when Eletriptan is combined with Firocoxib. |
| Isoetharine | The risk or severity of hypertension can be increased when Isoetharine is combined with Firocoxib. |
| Ziprasidone | The risk or severity of hypertension can be increased when Ziprasidone is combined with Firocoxib. |
| Methysergide | The risk or severity of hypertension can be increased when Methysergide is combined with Firocoxib. |
| Cabergoline | The risk or severity of hypertension can be increased when Cabergoline is combined with Firocoxib. |
| Zolmitriptan | The risk or severity of hypertension can be increased when Zolmitriptan is combined with Firocoxib. |
| Dihydroergotamine | The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Firocoxib. |
| Methylergometrine | The risk or severity of hypertension can be increased when Methylergometrine is combined with Firocoxib. |
| Norepinephrine | The risk or severity of hypertension can be increased when Norepinephrine is combined with Firocoxib. |
| Mirtazapine | The risk or severity of hypertension can be increased when Mirtazapine is combined with Firocoxib. |
| Phenylephrine | The risk or severity of hypertension can be increased when Phenylephrine is combined with Firocoxib. |
| Phenylpropanolamine | The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Firocoxib. |
| Promazine | The risk or severity of hypertension can be increased when Promazine is combined with Firocoxib. |
| Droperidol | The risk or severity of hypertension can be increased when Droperidol is combined with Firocoxib. |
| Doxapram | The risk or severity of hypertension can be increased when Doxapram is combined with Firocoxib. |
| Atropine | The risk or severity of hypertension can be increased when Atropine is combined with Firocoxib. |
| Lisuride | The risk or severity of hypertension can be increased when Lisuride is combined with Firocoxib. |
| Linezolid | The risk or severity of hypertension can be increased when Linezolid is combined with Firocoxib. |
| Metaraminol | The risk or severity of hypertension can be increased when Metaraminol is combined with Firocoxib. |
| Furazolidone | The risk or severity of hypertension can be increased when Furazolidone is combined with Firocoxib. |
| Epinephrine | The risk or severity of hypertension can be increased when Epinephrine is combined with Firocoxib. |
| Thioridazine | The risk or severity of hypertension can be increased when Thioridazine is combined with Firocoxib. |
| Ergotamine | The risk or severity of hypertension can be increased when Ergotamine is combined with Firocoxib. |
| Nicergoline | The risk or severity of hypertension can be increased when Nicergoline is combined with Firocoxib. |
| Sufentanil | The risk or severity of hypertension can be increased when Sufentanil is combined with Firocoxib. |
| Methoxamine | The risk or severity of hypertension can be increased when Methoxamine is combined with Firocoxib. |
| Risperidone | The risk or severity of hypertension can be increased when Risperidone is combined with Firocoxib. |
| Tranylcypromine | The risk or severity of hypertension can be increased when Tranylcypromine is combined with Firocoxib. |
| Isoflurane | The risk or severity of hypertension can be increased when Isoflurane is combined with Firocoxib. |
| Propiomazine | The risk or severity of hypertension can be increased when Propiomazine is combined with Firocoxib. |
| Alfentanil | The risk or severity of hypertension can be increased when Alfentanil is combined with Firocoxib. |
| Minaprine | The risk or severity of hypertension can be increased when Minaprine is combined with Firocoxib. |
| Orciprenaline | The risk or severity of hypertension can be increased when Orciprenaline is combined with Firocoxib. |
| Propofol | The risk or severity of hypertension can be increased when Propofol is combined with Firocoxib. |
| Phenmetrazine | The risk or severity of hypertension can be increased when Phenmetrazine is combined with Firocoxib. |
| Trifluoperazine | The risk or severity of hypertension can be increased when Trifluoperazine is combined with Firocoxib. |
| Pseudoephedrine | The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Firocoxib. |
| Benzphetamine | The risk or severity of hypertension can be increased when Benzphetamine is combined with Firocoxib. |
| Ritodrine | The risk or severity of hypertension can be increased when Ritodrine is combined with Firocoxib. |
| Flupentixol | The risk or severity of hypertension can be increased when Flupentixol is combined with Firocoxib. |
| Remifentanil | The risk or severity of hypertension can be increased when Remifentanil is combined with Firocoxib. |
| Bitolterol | The risk or severity of hypertension can be increased when Bitolterol is combined with Firocoxib. |
| Oxymetazoline | The risk or severity of hypertension can be increased when Oxymetazoline is combined with Firocoxib. |
| Diethylpropion | The risk or severity of hypertension can be increased when Diethylpropion is combined with Firocoxib. |
| Salmeterol | The risk or severity of hypertension can be increased when Salmeterol is combined with Firocoxib. |
| Naratriptan | The risk or severity of hypertension can be increased when Naratriptan is combined with Firocoxib. |
| Formoterol | The risk or severity of hypertension can be increased when Formoterol is combined with Firocoxib. |
| Frovatriptan | The risk or severity of hypertension can be increased when Frovatriptan is combined with Firocoxib. |
| Methoxyflurane | The risk or severity of hypertension can be increased when Methoxyflurane is combined with Firocoxib. |
| Selegiline | The risk or severity of hypertension can be increased when Selegiline is combined with Firocoxib. |
| Ergoloid mesylate | The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Firocoxib. |
| Isoprenaline | The risk or severity of hypertension can be increased when Isoprenaline is combined with Firocoxib. |
| Arbutamine | The risk or severity of hypertension can be increased when Arbutamine is combined with Firocoxib. |
| Dutasteride | The risk or severity of hypertension can be increased when Dutasteride is combined with Firocoxib. |
| Halothane | The risk or severity of hypertension can be increased when Halothane is combined with Firocoxib. |
| Moclobemide | The risk or severity of hypertension can be increased when Moclobemide is combined with Firocoxib. |
| Pergolide | The risk or severity of hypertension can be increased when Pergolide is combined with Firocoxib. |
| Desflurane | The risk or severity of hypertension can be increased when Desflurane is combined with Firocoxib. |
| Bromocriptine | The risk or severity of hypertension can be increased when Bromocriptine is combined with Firocoxib. |
| Finasteride | The risk or severity of hypertension can be increased when Finasteride is combined with Firocoxib. |
| Aripiprazole | The risk or severity of hypertension can be increased when Aripiprazole is combined with Firocoxib. |
| Isocarboxazid | The risk or severity of hypertension can be increased when Isocarboxazid is combined with Firocoxib. |
| Ergometrine | The risk or severity of hypertension can be increased when Ergometrine is combined with Firocoxib. |
| Lisdexamfetamine | The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Firocoxib. |
| Fenoterol | The risk or severity of hypertension can be increased when Fenoterol is combined with Firocoxib. |
| Pirbuterol | The risk or severity of hypertension can be increased when Pirbuterol is combined with Firocoxib. |
| Ephedra sinica root | The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Firocoxib. |
| Ephedrine | The risk or severity of hypertension can be increased when Ephedrine is combined with Firocoxib. |
| Mephentermine | The risk or severity of hypertension can be increased when Mephentermine is combined with Firocoxib. |
| Procaterol | The risk or severity of hypertension can be increased when Procaterol is combined with Firocoxib. |
| Yohimbine | The risk or severity of hypertension can be increased when Yohimbine is combined with Firocoxib. |
| Methotrimeprazine | The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Firocoxib. |
| Clenbuterol | The risk or severity of hypertension can be increased when Clenbuterol is combined with Firocoxib. |
| Bambuterol | The risk or severity of hypertension can be increased when Bambuterol is combined with Firocoxib. |
| MMDA | The risk or severity of hypertension can be increased when MMDA is combined with Firocoxib. |
| Midomafetamine | The risk or severity of hypertension can be increased when Midomafetamine is combined with Firocoxib. |
| 2,5-Dimethoxy-4-ethylamphetamine | The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Firocoxib. |
| 4-Methoxyamphetamine | The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Firocoxib. |
| 4-Bromo-2,5-dimethoxyamphetamine | The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Firocoxib. |
| Tenamfetamine | The risk or severity of hypertension can be increased when Tenamfetamine is combined with Firocoxib. |
| Chlorphentermine | The risk or severity of hypertension can be increased when Chlorphentermine is combined with Firocoxib. |
| Dextroamphetamine | The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Firocoxib. |
| Phendimetrazine | The risk or severity of hypertension can be increased when Phendimetrazine is combined with Firocoxib. |
| Solifenacin | The risk or severity of hypertension can be increased when Solifenacin is combined with Firocoxib. |
| Periciazine | The risk or severity of hypertension can be increased when Periciazine is combined with Firocoxib. |
| Acepromazine | The risk or severity of hypertension can be increased when Acepromazine is combined with Firocoxib. |
| Thioproperazine | The risk or severity of hypertension can be increased when Thioproperazine is combined with Firocoxib. |
| Zuclopenthixol | The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Firocoxib. |
| Epicaptopril | The risk or severity of hypertension can be increased when Epicaptopril is combined with Firocoxib. |
| Clorgiline | The risk or severity of hypertension can be increased when Clorgiline is combined with Firocoxib. |
| 1-benzylimidazole | The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Firocoxib. |
| Iproniazid | The risk or severity of hypertension can be increased when Iproniazid is combined with Firocoxib. |
| Nialamide | The risk or severity of hypertension can be increased when Nialamide is combined with Firocoxib. |
| Lysergic acid diethylamide | The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Firocoxib. |
| Dronedarone | The risk or severity of hypertension can be increased when Dronedarone is combined with Firocoxib. |
| Flibanserin | The risk or severity of hypertension can be increased when Flibanserin is combined with Firocoxib. |
| Iloperidone | The risk or severity of hypertension can be increased when Iloperidone is combined with Firocoxib. |